FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagehl7.fhir.uv.ebm
Resource TypeEvidenceVariable
IdEvidenceVariable-32143.json
FHIR VersionR6

Resources that use this resource

No resources found

Resources that this resource uses

No resources found

Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: EvidenceVariable 32143

version: 13; Last updated: 2023-12-06 21:24:16+0000

Profile: VariableDefinition

ArtifactPublicationStatus: Active

url: EvidenceVariable OutcomeVariable: American Diabetes Association composite triple end point for metabolic control at 5 years

identifier: FEvIR Object Identifier/32143, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.24.81

version: 1.0.0-ballot3

name: OutcomeVariable_American_Diabetes_Association_composite_triple_end_point_for_metabolic_control_at_5_years

title: OutcomeVariable: American Diabetes Association composite triple end point for metabolic control at 5 years

status: Active

date: 2022-05-28 12:16:43+0000

author: Brian S. Alper:

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss

description:

The American Diabetes Association composite triple end point of hemoglobin A1c less than 7.0%, low-density lipoprotein cholesterol less than 100 mg/dL, and systolic blood pressure less than 130 mm Hg at 5 years

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

actual: true

handling: dichotomous variable

Source1

{
  "resourceType": "EvidenceVariable",
  "id": "32143",
  "meta": {
    "versionId": "13",
    "lastUpdated": "2023-12-06T21:24:16.455Z",
    "profile": [
      "http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"
    ]
  },
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
      "valueCodeableConcept": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
            "code": "active",
            "display": "Active"
          }
        ]
      }
    }
  ],
  "url": "https://fevir.net/resources/EvidenceVariable/32143",
  "identifier": [
    {
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code": "ACSN",
            "display": "Accession ID"
          }
        ],
        "text": "FEvIR Object Identifier"
      },
      "system": "https://fevir.net/FOI",
      "value": "32143",
      "assigner": {
        "display": "Computable Publishing LLC"
      }
    },
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.4.642.40.44.24.81"
    }
  ],
  "version": "1.0.0-ballot3",
  "name": "OutcomeVariable_American_Diabetes_Association_composite_triple_end_point_for_metabolic_control_at_5_years",
  "title": "OutcomeVariable: American Diabetes Association composite triple end point for metabolic control at 5 years",
  "status": "active",
  "date": "2022-05-28T12:16:43.370Z",
  "author": [
    {
      "name": "Brian S. Alper"
    }
  ],
  "publisher": "HL7 International / Clinical Decision Support",
  "contact": [
    {
      "name": "HL7 International / Clinical Decision Support",
      "telecom": [
        {
          "system": "url",
          "value": "http://www.hl7.org/Special/committees/dss"
        }
      ]
    }
  ],
  "description": "The American Diabetes Association composite triple end point of hemoglobin A1c less than 7.0%, low-density lipoprotein cholesterol less than 100 mg/dL, and systolic blood pressure less than 130 mm Hg at 5 years",
  "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/",
  "actual": true,
  "handling": "dichotomous"
}